Glucose Management Interface With Haptic Dosing Feedback

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current diabetes management systems lack a user interface that provides enhanced control, functionality, and privacy, particularly in administering insulin doses and monitoring glucose levels.

Innovation Solution

The implementation of a user interface with haptic feedback capabilities, allowing users to input parameters through tactile contact and movement, providing feedback responses as entered values approach predefined limits or move away from preferred values.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If a user interface with haptic feedback is implemented, then user control and privacy are enhanced, but device complexity increases

Engineering Contradiction:
Improveuser controlVSAvoiddevice complexity
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The patent implements haptic feedback mechanisms that provide tactile responses to user inputs, enabling users to feel resistance or confirmation when adjusting parameters. This feedback loop enhances user control by allowing intuitive interaction without visual confirmation, while the feedback is generated through existing motor drivers and control circuits already present in the infusion device, thereby limiting the increase in overall device complexity.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The haptic feedback system enables the device to communicate its state and respond to user inputs autonomously through tactile sensations. The system self-regulates by providing natural resistance when approaching parameter limits or preferred values, eliminating the need for additional complex interfaces or communication channels while enhancing ease of operation.

Inventive Principle:
Principle #25Self-service

2Measurement precision

If haptic feedback is provided as user approaches predefined limits, then dosing accuracy is improved, but device complexity increases

Engineering Contradiction:
Improvedosing accuracyVSAvoiddevice complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system incorporates haptic feedback that activates when user-adjusted parameters approach predefined limits or preferred values. This feedback mechanism uses the existing motor driver circuits to generate tactile resistance or pulses, providing dosing accuracy enhancement without requiring separate dedicated hardware for limit detection and feedback generation, thus minimizing the increase in device complexity.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent utilizes changes in motor driver parameters (such as pulse width modulation duty cycle or frequency) to generate haptic feedback sensations. By dynamically adjusting these electrical parameters, the system creates tactile responses that indicate proximity to dosing limits, achieving improved dosing accuracy through software-controlled parameter modulation rather than additional hardware complexity.

Inventive Principle:
Principle #35Parameter changes

3Device complexity

If discrete button inputs are used, then device complexity is reduced, but ease of operation and privacy are compromised

Engineering Contradiction:
Improvedevice complexityVSAvoidprivacy
Core Design Contradiction:
Device complexityVSEase of operation

Solution Approach 1:

The patent enhances simple button inputs by incorporating haptic feedback mechanisms that provide tactile confirmation of button presses and parameter adjustments. This allows users to operate the device privately without visual confirmation, as the haptic responses provide intuitive feedback through touch alone. The feedback is generated using existing motor driver circuits, maintaining low device complexity while significantly improving ease of operation and user privacy.

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS12346508B2Systems, devices and methods for managing glucose levels
Publication Date: 2025.07.01 ABBOTT DIABETES CARE INC
  • US12346508B2 patent drawing
  • US12346508B2 patent drawing
  • US12346508B2 patent drawing

AI summary

Systems, devices and methods for the management of glucose levels in the body of patient featuring user interface input mechanisms configured to provide haptic feedback to the user are provided.